MICROPIRIN 75

Land: Israël

Taal: Engels

Bron: Ministry of Health

Koop het nu

Download Bijsluiter (PIL)
11-11-2023

Werkstoffen:

ACETYLSALICYLIC ACID

Beschikbaar vanaf:

DEXCEL LTD, ISRAEL

ATC-code:

B01AC06

farmaceutische vorm:

TABLETS ENTERIC COATED

Samenstelling:

ACETYLSALICYLIC ACID 75 MG

Toedieningsweg:

PER OS

Prescription-type:

Not required

Geproduceerd door:

DEXCEL LTD, ISRAEL

Therapeutische categorie:

ACETYLSALICYLIC ACID

Therapeutisch gebied:

ACETYLSALICYLIC ACID

therapeutische indicaties:

The primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

Autorisatie datum:

2020-04-30

Bijsluiter

                                PATIENT PACKAGE INSERT ACCORDING TO PHARMACISTS' REGULATIONS
(PREPARATIONS)
– 1986
This medicine can be sold without a physician’s prescription
MICROPIRIN
® 75, 100, ENTERIC COATED TABLETS
Each enteric-coated tablet contains acetylsalicylic acid at a dosage
of 75 or 100 mg,
respectively.
Inactive ingredients and allergens in the medicine - see section 6
"Additional information" and
in section 2 "Important information about some of the ingredients of
the medicine".
READ THIS ENTIRE LEAFLET CAREFULLY BEFORE USING THE MEDICINE. This
leaflet contains concise
information about the medicine. If you have any further questions, ask
the doctor or
pharmacist.
Take this medicine according to the instructions in section 3 "How to
use the medicine?" in
this leaflet. Consult the pharmacist if you need additional
information.
1.
WHAT IS THE MEDICINE INTENDED FOR?
The medicine is intended for primary prevention of coronary heart
disease in patients at
increased risk and secondary prevention of heart and brain disease
caused by arterial
thrombosis.
THERAPEUTIC GROUP: anticoagulant, platelet aggregation inhibitor.
MICROPIRIN inhibits the aggregation of blood platelets and in this way
prevents blood clots from
developing.
2.
BEFORE USING THE MEDICINE
DO NOT USE THE MEDICINE IF:

You are hypersensitive (allergic) to the active ingredient
(acetylsalicylic acid), salicylates or
any of the other ingredients this medicine contains (see section 6).

You have a history of reacting to certain medicines for pain, fever,
or inflammation
(salicylates or other nonsteroidal anti-inflammatory drugs)
experienced as asthma attacks
or other allergic reactions.

You have acute gastric or intestinal ulcers.

You have a tendency to disorders leading to bleeding.

You have kidney or liver failure.

You have severe heart failure which is not being adequately treated.

You are concurrently taking a 15 mg dosage of methotrexate or more a
week.

You are in your last trimester of pregnancy and are taking a daily
dosage above 150
                                
                                Lees het volledige document
                                
                            

Documenten in andere talen

Bijsluiter Bijsluiter Arabisch 11-11-2023
Bijsluiter Bijsluiter Hebreeuws 11-11-2023

Zoekwaarschuwingen met betrekking tot dit product

Bekijk de geschiedenis van documenten